Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34731
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-11-01T08:29:44Z-
dc.date.available2023-11-01T08:29:44Z-
dc.date.issued2007-03-
dc.identifier.citationFiliz, G. vd. (2007). "The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors". Hepato-Gastroenterology, 54(74), 438-441.en_US
dc.identifier.issn0172-6390-
dc.identifier.urihttp://hdl.handle.net/11452/34731-
dc.description.abstractBackground/Aims: Gastrointestinal stromal tumors (GIST) are mesenchymal tumors originating from the gastrointestinal canal wall. Although a number of studies are performed concerning prognostic factors, no indicators of recurrence or metastasis could be established. In this study we assessed the prognostic value of MIB-1 proliferative index (PI) in GIST, and whether there was a relationship to any other clinicopathological findings. Methodology: In the study 37 patients with GIST diagnosis were included. The cases were classified as low, intermediate, and high risk groups according to tumor size and mitotic activity. The average PI of 10% in high risk group was set as the cut-off value. Results: Of all the cases, those with a MIB-1 PI over the cut-off value had a significantly shorter survival (Log-rank test, p < 0.05). Likewise cases with small bowel tumors with. a MIB-1 PI over the cut-off value had a significantly shorter survival (Log-rank test, p < 0.05). A statistically significant negative correlation was found between presence of necrosis and survival using McPearson correlation test (p < 0.01). Conclusions: MIB-1 PI and presence of necrosis are possible indicators of prognosis especially in GIST cases of the small bowel.en_US
dc.language.isoenen_US
dc.publisherH.G.E. Update Medical Publishingen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subjectSurgeryen_US
dc.subjectGastrointestinal stromal tumoren_US
dc.subjectProliferative indexprognosisen_US
dc.subjectMib-1en_US
dc.subjectPrognostic valueen_US
dc.subjectDna-ploidyen_US
dc.subjectImmunoreactivityen_US
dc.subjectCellen_US
dc.subjectExpressionen_US
dc.subjectStomachen_US
dc.subjectKi-67en_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshBiopsyen_US
dc.subject.meshCell divisionen_US
dc.subject.meshFemaleen_US
dc.subject.meshGastrointestinal stromal tumorsen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunoenzyme techniquesen_US
dc.subject.meshIntestinal mucosaen_US
dc.subject.meshKi-67 antigenen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshMitotic indexen_US
dc.subject.meshPrognosisen_US
dc.subject.meshSurvival analysisen_US
dc.titleThe relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumorsen_US
dc.typeArticleen_US
dc.identifier.wos000246271800027tr_TR
dc.identifier.scopus2-s2.0-34248137859tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.tr_TR
dc.identifier.startpage438tr_TR
dc.identifier.endpage441tr_TR
dc.identifier.volume54tr_TR
dc.identifier.issue74tr_TR
dc.relation.journalHepato-Gastroenterologyen_US
dc.contributor.buuauthorFiliz, Gülaydan-
dc.contributor.buuauthorYalçınkaya, Ülviye-
dc.contributor.buuauthorGürel, Selim-
dc.contributor.buuauthorYerci, Ömer-
dc.contributor.buuauthorMemik, Faruk-
dc.contributor.researcheridEVQ-8652-2022tr_TR
dc.contributor.researcheridAAH-8924-2021tr_TR
dc.contributor.researcheridHLH-8209-2023tr_TR
dc.contributor.researcheridEIS-5114-2022tr_TR
dc.contributor.researcheridDGO-4135-2022tr_TR
dc.identifier.pubmed17523292tr_TR
dc.subject.wosGastroenterology & hepatologyen_US
dc.subject.wosSurgeryen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3 (Surgery)en_US
dc.wos.quartileQ4 (Gastroenterology & hepatology)en_US
dc.contributor.scopusid6602693514tr_TR
dc.contributor.scopusid6508300295tr_TR
dc.contributor.scopusid7003706434tr_TR
dc.contributor.scopusid6603810549tr_TR
dc.contributor.scopusid6701813462tr_TR
dc.subject.scopusGastrointestinal Stromal Tumors; Imatinib; Canceren_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGastrointestinal stromal tumoren_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMitosis indexen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSurvivalen_US
dc.subject.emtreeTumor localizationen_US
dc.subject.emtreeTumor volumeen_US
dc.subject.emtreeKi 67 antigenen_US
Appears in Collections:PubMed
Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.